Global Liver-on-Chip Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Type;

Child Liver-on-a-chip and Adult Liver-on-a-chip.

By Application;

Drug Discovery, Toxicology Research and Disease Model Development.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn823122286 Published Date: October, 2024 Updated Date: November, 2024

Introduction

Global Liver-on-Chip Market (USD Million), 2020 - 2030

In the year 2023, the Global Liver-on-Chip Market was valued at USD 190.48 million. The size of this market is expected to increase to USD 908.28 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 25.0%.

The global liver-on-chip market is experiencing significant growth driven by advancements in biotechnology and the increasing demand for alternatives to traditional preclinical testing methods. Liver-on-chip technology represents a transformative approach in the field of biomedical research, offering a sophisticated platform that mimics the physiological and functional characteristics of the human liver in a controlled environment. This technology holds immense promise for applications in drug development, toxicity testing, and disease modeling, providing more accurate and reliable results compared to conventional cell cultures or animal models.

One of the primary factors propelling the growth of the liver-on-chip market is its ability to replicate the complex architecture and cellular interactions of the liver. These microscale devices incorporate living liver cells cultured within microfluidic channels, allowing researchers to simulate the dynamic microenvironment of the organ. Such precision in modeling liver function enables pharmaceutical companies to screen drug candidates more effectively and predict human responses with greater fidelity, thereby reducing the risk of drug failures during clinical trials.

The escalating cost of drug development and regulatory pressures to enhance safety assessments have intensified the demand for innovative in vitro models like liver-on-chip. These systems not only offer a more ethical alternative to animal testing but also provide a more cost-effective and time-efficient means of evaluating drug efficacy and toxicity. As a result, pharmaceutical and biotechnology companies are increasingly investing in liver-on-chip technology to streamline their drug discovery processes and accelerate time-to-market for new therapies.

In addition to its applications in pharmaceutical research, the liver-on-chip market is expanding into personalized medicine and precision health initiatives. The ability to customize these microphysiological systems using patient-derived cells opens new avenues for studying liver diseases, understanding individual drug responses, and developing personalized treatment strategies. This personalized approach is expected to drive further innovation and adoption of liver-on-chip technology across both research institutions and clinical settings, positioning it as a cornerstone of future biomedical advancements.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global Liver-on-Chip Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Biopharmaceutical research demand
        2. Advancements in microfluidic technology
        3. Need for alternative to animal testing
        4. Rising prevalence of liver diseases
      2. Restraints
        1. High cost of technology adoption
        2. Complex regulatory landscape
        3. Limited awareness and accessibility
        4. Challenges in mimicking organ functions
      3. Opportunities
        1. Increasing R&D investments
        2. Growing collaborations and partnerships
        3. Personalized medicine advancements
        4. Expansion in drug toxicity testing
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Liver-on-Chip Market, By Type, 2020 - 2030 (USD Million)
      1. Child Liver-on-a-chip
      2. Adult Liver-on-a-chip
    2. Global Liver-on-Chip Market, By Application, 2020 - 2030 (USD Million)
      1. Drug Discovery
      2. Toxicology Research
      3. Disease Model DevelopmentT
    3. Global Liver-on-Chip Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Emulate Inc
      2. CN Bio Innovations Ltd
      3. Tara Biosystems
      4. Hesperos Inc
      5. Nortis Bio
      6. Kirkstall Ltd
      7. Mimetas
      8. Cherry Biotech
      9. InSphero AG
      10. TissUse GmbH
  7. Analyst Views
  8. Future Outlook of the Market